By allowing us, to count your visits on our website, you support us optimizing the supply for our users. For that purpose we apply cookies. The recorded information will not be passed on to third- parties. You will find more information in our Data Privacy Statement. For details of our website service providers, please refer to our legal notice: legal notice
Currently, 29 member states strive to win the fight against the societal challenge AMR poses today. Created as a European initiative in 2011 and functioning as a collaboration of international funders, the JPIAMR includes members from five different continents. By now, JPIAMR has invested €170 million in basic and exploratory research on new antibiotics, stewardship, as well as in studies on controlling the spread of antibiotic resistance. The JPIAMR is emphasizing the “One Health” approach in all activities and actions. Based on joint transnational calls, the ultimate aim of the JPIAMR is to join forces between scientists and other stakeholders, e.g. industry, policy makers, or health care systems representatives.
Complementing its national and international engagements, the German Federal Ministry of Education and Research (BMBF) has funded continuously projects with around € 2 to 3 million per year in JPIAMR calls starting from 2015. The BMBF participates regularly in the joint transnational calls of JPIAMR with a substantial funding, takes part in various working groups and the Steering Committee, and thus helps to shape the actions and direction of the initiative.
In its Strategic Research and Innovation Agenda (SRIA), the JPIAMR prioritizes topics and key areas in AMR with the support from experts in the field. As a point of reference, the SRIA can provide guidance for policy makers, researchers and the private sector for setting up own agendas and align them internationally.